0001567619-19-012278.txt : 20190528
0001567619-19-012278.hdr.sgml : 20190528
20190528201856
ACCESSION NUMBER: 0001567619-19-012278
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190523
FILED AS OF DATE: 20190528
DATE AS OF CHANGE: 20190528
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Zoon Kathryn C
CENTRAL INDEX KEY: 0001685720
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33137
FILM NUMBER: 19859446
MAIL ADDRESS:
STREET 1: 400 PROFESSIONAL DRIVE
STREET 2: SUITE 400
CITY: GAITHERSBURG
STATE: MD
ZIP: 20879
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Emergent BioSolutions Inc.
CENTRAL INDEX KEY: 0001367644
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 141902018
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 400 PROFESSIONAL DR, SUITE 400
CITY: GAITHERSBURG
STATE: MD
ZIP: 20879
BUSINESS PHONE: 240-631-3200
MAIL ADDRESS:
STREET 1: 400 PROFESSIONAL DR, SUITE 400
CITY: GAITHERSBURG
STATE: MD
ZIP: 20879
4
1
doc1.xml
FORM 4
X0306
4
2019-05-23
0
0001367644
Emergent BioSolutions Inc.
EBS
0001685720
Zoon Kathryn C
400 PROFESSIONAL DRIVE
GAITHERSBURG
MD
20879
1
0
0
0
Common Stock
2019-05-23
4
A
0
5736
0
A
24379
D
Common Stock
2019-05-28
4
S
0
1376
43.3884
D
23003
D
Consists of restricted stock units granted under the Emergent BioSolutions Inc. Stock Incentive Plan.
These restricted stock units vest in three equal annual installments beginning on the earlier of: (i) the day prior to the first anniversary of the date of grant, or (ii) the day prior to annual shareholder meeting; assuming continued service with the company.
The sale transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Dr. Zoon.
The price reported is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $43.04 to $43.58, inclusive.
/s/ S. Scott Liberman, Attorney-in-fact
2019-05-28